Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 31/05/13 → 30/04/14 |
Funding
- MSD (Merck Sharp & Dohme Australia) Pty Ltd: A$90,000.00
Educational research grant for Australian Boceprevir CUPIC Study evaluating safety outcomes in patients with chronic Hepatitis C Genotype 1 receiving Boceprevir based triple therapy
- Dev, Anouk (Primary Chief Investigator (PCI))
Project: Research